RossWannerMD

Physician

Dr. Wanner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

University of Kentucky College of MedicineResidency, Emergency Medicine, 2020 - 2023
Ohio State University College of MedicineClass of 2020

PubMed

199 citations
Hypoxia-induced exosomes contribute to a more aggressive and chemoresistant ovarian cancer phenotype: a novel mechanism linking STAT3/Rab proteins
Kalpana Deepa Priya Dorayappan, Ross Wanner, John J. Wallbillich, Uksha Saini, Roman A. Zingarelli
Oncogene. 2018-04-11
26 citations
Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.
Kristin Bixel, Uksha Saini, Hemant Kumar Bid, John Fowler, Maria Riley
International Journal of Cancer. 2017-11-01
13 citations
Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.
Adam C. ElNaggar, Uksha Saini, Shan Naidu, Ross Wanner, Millie Sudhakar
Cancer Biology & Therapy. 2016-07-14

Journal Articles

STAT3/PIAS3 Levels Serve as “Early Signature” Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube
Saini U, Suarez AA, Naidu S, Wallbillich JJ, Bixel K, Wanner RA, Bice J, Kladney RD, Lester J, Karlan BY, Goodfellow PJ, Cohn DE, Selvendiran K, Cancer Research, 1/16/2018